Multimodal treatment for high-risk prostate cancer with high-dose intensity-modulated radiation therapy preceded or not by radical prostatectomy concurrent intensified-dose docetaxel and long-term androgen deprivation therapy: results of a prospective phase II trial

摘要

BackgroundThe optimal management of high-risk prostate cancer remains uncertain. In this study we assessed the safety and efficacy of a novel multimodal treatment paradigm for high-risk prostate cancer.